dc.contributor.author | Fredrikson, GN | en_US |
dc.contributor.author | Anand, DV | en_US |
dc.contributor.author | Hopkins, D | en_US |
dc.contributor.author | Corder, R | en_US |
dc.contributor.author | Alm, R | en_US |
dc.contributor.author | Bengtsson, E | en_US |
dc.contributor.author | Shah, PK | en_US |
dc.contributor.author | Lahiri, A | en_US |
dc.contributor.author | Nilsson, J | en_US |
dc.date.accessioned | 2016-09-30T17:08:17Z | |
dc.date.available | 2009-04-01 | en_US |
dc.date.issued | 2009-07 | en_US |
dc.date.submitted | 2016-09-16T11:19:23.758Z | |
dc.identifier.issn | 0012-186X | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/15670 | |
dc.description.sponsorship | Supported by grants from the Swedish Medical Research Council, the Swedish Heart-Lung foundation,
the Söderberg foundation, the Albert Påhlsson foundation, the
Knut and Alice Wallenberg foundation, the Malmö University
Hospital foundation, the Lundström Foundation, the Crafoord Foundation,
the Harrow Cardiovascular Research Trust, Michael Tabor
Foundation, GE Healthcare, Bristol Myers Squibb Medical Imaging
and the Derrick Smith Research Grant. | en_US |
dc.format.extent | 1426 - 1433 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | DIABETOLOGIA | en_US |
dc.rights | This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. | |
dc.rights | The final publication is available at Springer via http://dx.doi.org/10.1007/s00125-009-1377-9 | |
dc.subject | Antibodies | en_US |
dc.subject | Low-density lipoprotein | en_US |
dc.subject | Oxidation | en_US |
dc.subject | Peripheral neuropathy | en_US |
dc.subject | Retinopathy | en_US |
dc.subject | CORONARY-ARTERY-DISEASE | en_US |
dc.subject | LOW-DENSITY-LIPOPROTEIN | en_US |
dc.subject | ALDEHYDE-MODIFIED PEPTIDE | en_US |
dc.subject | OXIDIZED LDL | en_US |
dc.subject | HYPERCHOLESTEROLEMIC RABBITS | en_US |
dc.subject | IMMUNE-RESPONSES | en_US |
dc.subject | DEFICIENT MICE | en_US |
dc.subject | RISK-FACTORS | en_US |
dc.subject | ATHEROSCLEROSIS | en_US |
dc.subject | IMMUNIZATION | en_US |
dc.title | Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes | en_US |
dc.type | Article | |
dc.rights.holder | (c) 2009 The Authors | |
dc.identifier.doi | 10.1007/s00125-009-1377-9 | en_US |
pubs.issue | 7 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 52 | en_US |